US-based healthcare provider Northwell Health launched a healthcare company building platform called Ascertain with venture studio Aegis Ventures yesterday equipped with $100m in capital.
Ascertain will focus on creating and seeding artificial intelligence-powered healthcare technology startups capable of improving access to healthcare and closing equity gaps within the space.
The vehicle is employing a three-pronged strategy comprising of internal idea creation, the commercialisation of scientific breakthroughs by academics and other entrepreneurs and the facilitation of US market entry for global ventures.
Northwell will provide Ascertain access to data, research, product testing and commercialisation capabilities in order to speed up the implementation process and prevent feedback loops which could slow startups down.
Ascertain is working on its first portfolio company, which aims to improve maternal health. It is collaborating with Northwell’s Center for Maternal Health to detect and manage complications such as preeclampsia, a disorder caused by high blood pressure that can damage organs and which disproportionately affects expectant black mothers.
Michael Dowling, president and chief executive of Northwell Health, said: “Ascertain brings a unique structure, an innovative approach, and a compelling vision to create breakthrough healthcare AI companies that are set up for success.
“We are all driven by the idea that everyone deserves access to high-quality, affordable healthcare. Our aim is clear: to find new, cost-efficient ways to create and accelerate companies that deliver real, equitable solutions.”
